Strategies for the development of the urinary catheter

Expert Review of Medical Devices

Volumn 4, Issue 2, 2007, Pages 215-225

  Hamill, Turlough M ^a   Gilmore, Brendan F ^a   Jones, David S ^a   Gorman, Sean P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Antimicrobial; Device related infection; Hydroxyapatite; Microbial biofilm; Struvite; Urease; Urinary catheter; Urinary encrustation

Indexed keywords

ACETOHYDROXAMIC ACID; ANTIBIOTIC AGENT; BIOMATERIAL; FLUROFAMIDE; GENTAMICIN; LATEX; MACROGOL; MINOCYCLINE; NITROFURAL; NORFLOXACIN; POLITEF; POLYMACON; POLYURETHAN; PROTAMINE SULFATE; RIFAMPICIN; SILICONE; SILVER; TRICLOSAN; UREASE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BACTERIURIA; BALLOON CATHETER; BIOCOMPATIBILITY; BIOFILM; BLADDER CARCINOMA; BLADDER CATHETERIZATION; BLADDER DISTENSION; CATHETER INFECTION; CATHETER OCCLUSION; CLINICAL TRIAL; COMPOSITE MATERIAL; DRUG EFFICACY; ENZYME ACTIVITY; EQUIPMENT DESIGN; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; HYDROGEL; INDWELLING CATHETER; INFECTION PREVENTION; INTERMETHOD COMPARISON; IONTOPHORESIS; META ANALYSIS; NONHUMAN; PYELONEPHRITIS; REVIEW; RISK REDUCTION; SEPTICEMIA; SHOCK; SPINE INJURY; SYSTEMATIC REVIEW; TREATMENT INDICATION; URINARY TRACT INFECTION; URINE CATHETER; URINE PH; URINE RETENTION; UROLITHIASIS;

BACTERIAL INFECTIONS; CATHETERS, INDWELLING; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; PROSTHESIS-RELATED INFECTIONS; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 34047162452     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.4.2.215     Document Type: Review

References (93)

1. Beiko DT, Knudsen BE, Watterson JD, Cadieux PA, Reid G, Denstedt JD. Urinary tract. Biomaterials J. Urol. 171(6 Pt 1), 2438-2444 (2004).
2. Carr HA. A short history of the Foley catheter: from handmade instrument to infection-prevention device. J. Endourol. 14(1), 5-8 (2000).
3. Saint S, Lipsky BA, Goold SD. Indwelling urinary catheters: a one-point restraint? Ann. Inter. Med. 137(2), 125-127 (2002).
4. Maki DG, Tambyah PA. Engineering out the risk of infection with urinary catheters. Emerg. Infect. Dis. 7(2), 1-6 (2001).
5. Saint S, Wiese J, Amory JK et al. Are physicians aware of which of their patients have indwelling urinary catheters? Am. J. Med. 109(6), 476-480 (2000).
6. Weinstein JW, Mazon D, Pantelick E, Reagan-Cirincione P. Dembry LM, Hierholzer WJ Jr. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization and patient acuity. Infect. Control Hosp. Epidemiol. 20(8), 543-548 (1999).
7. Saint S, Lipsky BA, Goold SD. Indwelling urinary catheters: a one-point restraint? Ann. Inter. Med. 137(2), 125-127 (2002).
8. Toughill E. Indwelling urinary catheters: common mechanical and pathogenic problems. Am. J. Nurs. 105(5), 35-37 (2005).
9. Gray M. What nursing interventions reduce the risk of symptomatic urinary tract infection in the patient with an indwelling catheter? J. Wound Ostomy. Continence Nurs. 31(1), 3-13 (2004).
10. Maki DG, Tambyah PA. Engineering out the risk of infection with urinary catheters. Emeng. Infect. Dis. 7(2), 1-6 (2001).
11. Pomfret I. Urinary catheters: selection, management and prevention of infection. Br. J. Community Nurs. 5 (1), 6-8 (2000).
12. Drinka PJ. Complications of chronic indwelling urinary catheters. J. Am. Med. Dir. Assoc. 7(6), 388-392 (2006).
13. Leone M, Garnier F, Avidan M, Martin C. Catheter-associated urinary tract infections in intensive care units. Microbes Infect. 6(11), 1026-1032 (2004).
14. Choong S, Wood S, Fry C, Whitfield H. Catheter associated urinary tract infection and encrustation. Int. J. Antimicrob. Agents 17(4), 305-310 (2001).
15. Johnson JR, Kuskowski MA, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann. Intern. Med. 144(2), 116-126 (2006).
16. Brosnahan J, Jull A, Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst. Rev. 1, CD004013 (2004).
17. Keane PF, Bonner MC, Johnston SR, Zafia A, Gorman SP. Caracterization of biofilms and encrustation on ureteric stents in vitro. Br. J. Urol. 73(6). 687-691 (1994).
18. Stickler DJ, Evans A, Morris, Hughes G. Strategies for the control of catheter encrustation. Int. J. Antimicrob. Agents 19(6), 499-506 (2002).
19. Bonner M, Keane PF, Gorman SP. Characterization and antibiotic sensitivities of isolates from urethral stent biofilm. J. Pharm. Pharmacol. 45, 1445 (1993).
20. Warren JW. Catheter-associated urinary tract infections. Int. J. Antimicrob. Agents 17(4), 299-303 (2001).
21. Stickler DJ, McLean RJC. Biomaterial associated infections: the scale of the problem. Cell. Mater. 5, 167-182 (1995).
22. Kunin CM, Douthitt S, Dancing J, Anderson J, Moeschberger M. The association between the use of urinary catheters and morbidity and mortality among elderly patients in nursing homes. Am. J. Epidemiol. 135(3), 291-301 (1992).
23. Stickler DJ, Zimakoff J. Complications of urinary tract infections associated with devices used for long-term bladder management. J. Hosp. Infect. 28(3), 177-194 (1994).
24. Locke JR, Hill DE, Walzer Y. Incidence of squamous cell carcinoma in patients with long term catheter drainage. J. Urol. 133(6), 1034-1035 (1985).
25. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am. J. Infect. Control 28(1), 68-75 (2000).
26. Coello R, Glenister H, Fereres J et al. The cost of infection in surgical patients: a case control study. J. Hosp. Infect. 25(4), 239-250 (1993).
27. Rouprêt M, Daudon M, Hupertan V, Gattegno B, Thibault P, Traxer O. Can urinary stent encrustation analysis predict urinary stone composition? Urology 66(2), 246-251 (2005).
28. Sabbura NA, Stickler DJ, Mahenthiralingam E et al. Genotyping demonstrates that the strains of Proteus mirabilis from bladder stones and catheter encrustations of patients undergoing long-term bladder catheterization are identical. J. Urol. 171(5), 1925-1928 (2004).
29. Morris NS, Stickler DJ. Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine. J. Hosp. Infect. 39(3), 227-234 (1998).
30. Jones BD, Mobley HL. Genetic and biochemical diversity of ureases of Proteus, Providencia and Morganella species isolated from urinary tract infection. Infect. Immun. 55(9), 2198-2203 (1987).
31. Liedl B. Catheter-associated urinary tract infections. Curr. Opin. Urol. 11(1), 75-79 (2001).
32. Belas R, Suvanasuthi R. The ability of Proteus mirabilis to sense surfaces and regulate virulence gene expression involves FliL, a flagellar basal body protein. J. Bacteriol. 187(19), 6789-6803 (2005).
33. Dumanski AJ, Hedelin H, Edin-Liljegren A, Beauchemin D, McLean RJ. Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi, Infect. Immun. 62(7), 2998-3003 (1994).
34. Rozalski A, Sidorczyk Z, Kotelko K. Potential virulence factors of Proteus bacilli. Microbiol. Mol. Biol. Rev. 61(1), 65-89 (1997).
35. Santin M, Motta A, Denyer SP, Cannas M. Effect of the urine conditioning film on ureteral stent encrustation and characterization of its protein composition. Biomaterials 20(13), 1245-1251 (1999).
36. Gorman SP, McGovern JG, Woolfson AD, Adair CG, Jones DS. The concomitant development of poly(vinyl chloride)-related biofilm and antimicrobial resistance in relation to ventilator-associated pneumonia. Biomaterials 22(20), 2741-2747 (2001).
37. Gorman SP, Tunney MM. Assessment of encrustation behaviour of urinary tract biomaterials. J. Biomater. Appl. 12(2), 136-166 (1997).
38. Hedelin H, Edin-Liljegren A, Grenabo L. E. coli and urease-induced crystallisation in urine. Scand. J. Urol. Nephrol. 24(1), 57-61 (1990).
39. Hedelin H. Uropathogens and urinary tract concretion formation and catheter encrustations. Int. J. Antimicrob. Agents 19(6), 484-487 (2002).
40. Suller MT, Anthony VJ, Mathur S, Feneley RC, Greenman J, Stickler DJ. Factors modulating the pH at which calcium and magnesium phosphates precipitate from human urine. Urol. Res. 33(4), 254-260 (2005).
41. Mathur S, Suller MT, Stickler DJ, Feneley CL. Prospective study of individuals with long-term urinary catheters colonized with Proteus species. Br. J. Urol. 97(1), 121-128 (2006).
42. Torzewska, A, Staczek P, Rozalski A. Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides. J. Med. Microbiol. 52(6), 471-477 (2003).
43. Hedelin H, Bratt CG, Eckerdal G, Lincoln K. Relationship between urease-producing bacteria, urinary pH and encrustation on indwelling urinary catheters. Br. J. Urol. 67(5), 527-531 (1991).
44. Tunney MM, Keane PF, Gorman SP. Assessment of urinary tract biomaterial encrustation using a modified Robbins device continuous flow model. J. Biomed. Mater. Res. Part B Appl, Biomater. 38, 87-93 (1997).
45. Tuney MM, Bonner MC, Keane PF, Gorman SP Development of a model for assessment of biomaterial encrustation in the upper urinary tract. Biomaterials 17(10), 1025-1029 (1996)
46. Lawrence EL, Turner IG. Materials for urinary catheters: a review of their history and development in the UK. Med. Eng. Phys. 27(6), 443-453 (2005).
47. Ferrie BG, Groome J, Sethia B, Kirk D. Comparison of silicone and latex catheters in the development of urethral stricture after cardiac surgery. Br. J. Urol. 58(5), 549-550 (1986).
48. Denstedt JD, Wollin TA, Reid G. Biomaterials used in urology: current issues of biocompatibility infection and encrustation. J. Endourol. 12(6), 493-500 (1998).
49. Morris NS, Stickler DJ, Winters C. Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br. J. Urol. 80(1), 58-63 (1997).
50. Jones DS, Garvin CP, Gorman SP. Design of a simulated urethra model for the quantitative assessment of urinary catheter lubricity. J. Mater. Sci. Mater. Med. 12(1), 15-21 (2001).
51. Piechota HJ, Pannek J. Catheter drainage of the urinary tract. Status of the technique and prospects. Urologe A. 42(8), 1060-1069 (2003).
52. Sabbuba N, Hughes G, Stickler DJ. The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int. 89(1), 55-60 (2002).
53. Roberts JA, Fussell EN, Kaack MB. Bacterial adherence to urethral catheters. J. Urol. 144(2 Pt 1), 264-269 (1990).
54. Cormio L, La Forgia P, LaForgia D, Siitonen A, Ruutu M. Bacterial adhesion to urethral catheters: role of coating materials and immersion in antibiotic solution. Eur. Urol. 40(3), 354-358 (2001).
55. Bull E, Chilton CP, Gould CA, Sutton TM. Single-blind, randomised, parallel group study of the Bard Biocath catheter and a silicone elastomer coated catheter. Br. J. Urol. 68(4), 394-399 (1991).
56. Gorman SP. Woolfson AD, McCafferty DE. Microbial adherence and biofilm formation on latex and polymer-coated urinary catheters; role of hydrophobicity. Proc. 10th Pharmaceutical Conference, Bologna, Italy, 661-663 (1991).
57. Denyer SP, Hanlon GW, Davies MC, Gorman SP. Antimicrobial and other methods for controlling microbial adhesion in infection. In: Microbial Biofilms: Formation and Control. Denyer SP, Gorman SP, Sussman M (Eds). Oxford Blackwell Scientific Publications, London, UK, 147-165 (1993).
58. Tunney MM, Gorman SP. Evaluation of a poly(vinyl pyrollidone) -coated biomaterial for urological use. Biomaterials 23(23), 4601-4608 (2002).
59. Park JH, Cho YW, Kwon IC, Jeong SY, Bae YH. Assessment of PEO/PTMO multiblock copolymer/segmented polyurethane blends as coating materials for urinary catheters: in vitro bacterial adhesion and encrustation behavior. Biomaterials 23(19), 3991-4000 (2002).
60. Brehmer B, Marsden PO. Route and prophylaxis of ascending bladder infection in male patients with indwelling catheters. J. Urol. 108(5), 719-721 (1972).
61. Stickler DJ, Morris NS, Williams TJ. An assessment of the ability of a silver-releasing device to prevent bacterial contamination of urethral catheter drainage systems. Br. J. Urol. 78(4), 579-588 (1996).
62. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver coated urinary catheters in preventing urinary infection: a metaanalysis. Am. J. Med. 105(3), 236-241 (1998).
63. Trautner BW, Hull RA, Darouiche RO. Prevention of catheter-associated urinary tract infection. Curr. Opin. Infect. Dis. 18(1), 37-41 (2005).
64. Srinivasan A, Karchmer T, Richards A, Song X, Perl TM. A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect. Control Hosp. Epidemiol. 27(1), 38-43 (2006).
65. Niel-Weise BS, Arend SM, van den Broeck PJ. Is there evidence for recommending silver-coated urinary catheters in guidelines? J. hosp. Infect. 52(2), 81-87 (2002).
66. Stewart MJ, Parikh S, Xiao G, Tonge PJ, Kisker C. Structural basis and mechanism of enoyl reductase inhibition by triclosan. J. Mol. Biol. 290(4), 859-865 (1999).
67. Stickler DJ, Jones GL, Russell AD. Control of blockage and encrustation of Foley catheters. Lancet 361 (9367), 1435-1437 (2003).
68. Bibby JM, Cox AJ, Hukins DW. Feasibility of preventing encrustation of urinary catheters. Cell Mater. 2, 183-95 (1995).
69. Jones GL, Russell AD, Caliskan Z, Stickler DJ. A strategy for the control of blockage of catheter blockage by crystalline Proteus mirabilis biofilm using the antimicrobial agent triclosan. Eur. Urol. 48(5), 838-845 (2005).
70. Jones GL, Muller CT, O'Reilly M, Stickler DJ. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary. catheters. J. Antimicrob. Chemother. 57(2), 266-272 (2006).
71. Cadieux PA, Chew BH, Knudsen BE et al. Triclosan loaded ureteral stents decrease Proteus mirabilis 296 infection in a rabbit urinary tract infection model. J. Urol. 175(6), 2331-2335 (2006).
72. Johnson JR, Berggren T, Conway AJ. Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens. Antimicrob. Agents. Chemother. 37(9), 2033-2036 (1993).
73. Lee SJ, Kim SW, Cho YH et al. A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. Int. J. Antimicrob. Agents 24 (Suppl. 1), S65-S69 (2004).
74. Al-Habdan I, Sadat-Ali M, Corea JR, Al-Othman A, Kamal BA, Shrivan DS. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. Int. Surg. 88(3), 152-154 (2003).
75. Maki DG, Knasinski V, Halvorson KT, Tambyah PA, Holcomb RG. A prospective, randomized, investigator-blinded trial of a novel nitrofurazone-impregnated urinary catheter. Infect. Control Hosp. Epidemiol. 18(Suppl.), 50 (1997).
76. Park JH, Cho YW, Cho YH et al. Norfloxacin-releasing urethral catheter for long-term catheterization. J. Biomater. Sci. Polym. Ed. 14(9), 951-962 (2003).
77. Cho YH, Lee SJ, Lee JY et al. Prophylactic efficacy of a new gentamicin-releasing urethral catheter in short-term catheterized rabbits. BJU Int. 87(4), 104-109 (2001).
78. Gaonkar TA, Sampath LA, Modak SM. Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model. Infect. Control Hosp. Epidemiol. 24(7), 506-513 (2003).
79. Jones DS, Andrews GP, Gorman SP. Characterization of crosslinking effects on the physicochemical and drug diffusional properties of cationic hydrogels designed as bioactive urological biomaterials. J. Pharm. Pharmacol. 57(10), 1251-1259 (2005).
80. Chaiban G, Hanna H, Dvorak T, Raad I. A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent. J. Antimicrob. Chemother. 55(1), 51-56 (2005).
81. Darouiche RO, Smith JA, Hanna H et al, Efficacy of antimicrobial-impregnated ladder catheters in reducing catheter-associated bacteruria: a prospective randomized, multicenter clinical trial. Urology 54(6), 976-981 (1999).
82. Maki DG, Tambyah PA. Engineering out the risk of infection with urinary catheters. Emerg. Infect. Dis. 7(2), 1-6 (2001).
83. Griffith DP, Musher DM. Acetohydroxamic acid. Potential use in urinary infection caused by urea-splitting bacteria. Urology 5(3), 299-302 (1975).
84. Griffith DP, Gibson JR, Clinton CW, Musher DM. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. J. Urol. 119(1), 9-15 (1978).
85. Millner OE Jr, Andersen JA, Appler ME et al. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones. J. Urol. 127(2), 346-350 (1982).
86. Morris NS, Stickler DJ. The effect of urease inhibitors on the encrustation of urethral catheters. Urol. Res. 26(4), 275-279 (1998).
87. Burton E, Gawande PV, Yakandawala N et al. Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens. Antimicrob. Agents Chemother. 50(5), 1835-1840 (2006).
88. Davis CP, Anderson MD, Hoskins S, Warren MM. Electrode and bacterial survival with iontophoresis in synthetic urine. J. Urol. 147(5), 1310-1313 (1992).
89. Costerton JW, Ellis B, Lam K, Johnson F, Khoury AE. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob. Agents Chemother. 38(12), 2803-2809 (1994).
90. Chakravarti A, Gangodawila S, Long MJ, Morris NS, Blacklock AR, Stickler DJ. An electrified catheter to resist encrustation by Proteus mirabilis biofilm. J. Urol. 174 (3), 1129-1132 (2005).
91. Stickler D, Young R, Jones G, Sabbuba N, Morris N. Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm? Urol. Res. 31(5), 306-311(2003).
92. Sabbuba NA, Stickler DJ, Long MJ, Dong Z, Short TD, Feneley RJC. Does the valve regulated release of urine from the bladder decrease encrustation and blockage of indwelling catheters by crystalline Proteus mirabilis biofilms? J. Urol. 173(1), 262-266 (2005).
93. Lawrence EL, Turner IG. Kink, flow and retention properties of urinary catheters part 1: conventional foley catheters. J. Mater. Sci. Mater. Med. 17(2), 147-152 (2006).